COMMUNIQUÉS West-GlobeNewswire

Theratechnologies annoncera ses résultats pour l’exercice financier 2017

30/01/2018 - 15:32

MONTRÉAL, 30 janv. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX: TH ) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers mercredi le 7 février 2018 pour l’exercice [...]

ARM and NAMCP Publish Study of Managed Care Medical Director Perspectives on Value Demonstration and Reimbursement for Regenerative and Advanced Therapies

30/01/2018 - 15:30

WASHINGTON, DC., Jan. 30, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) and the National Association of Managed Care Physicians (NAMCP) Medical Directors Institute announced today the joint [...]

Fexapotide BPH Phase 3 Clinical Trial Results Published in World Journal of Urology

30/01/2018 - 15:30

HASBROUCK HEIGHTS, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) reports today that the results of Phase 3 clinical studies of Fexapotide Triflutate undertaken from 2009-2016 [...]

PCI Synthesis Submits Patent for Synthesizing Azelaic Acid

30/01/2018 - 15:15

NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and [...]

Utah Medical Products, Inc. Reports Audited Financial Performance for Fourth Quarter and Year 2017

30/01/2018 - 15:00

SALT LAKE CITY, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Utah Medical Products, Inc. (Nasdaq: UTMD ) concluded an outstanding year in 2017 in which it harvested distribution changes that had been in the making for several [...]

INSYS Therapeutics Adds Two New Executives to Senior Management Team

30/01/2018 - 15:00

VP of Human Resources, Carol Summersgill; VP of Clinical Development, Dr. Ahmed Elkashef PHOENIX, Jan. 30, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and [...]

Amarin Prices Public Offering of American Depositary Shares

30/01/2018 - 14:58

BEDMINSTER, N.J. and DUBLIN, Ireland, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ) today announced the pricing of the underwritten public offering of its American Depositary Shares ("ADSs") [...]

ChartMaxx® from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’

30/01/2018 - 14:48

Secaucus, NJ, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that its ChartMaxx ® enterprise content management solution [...]

Elite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot Study

30/01/2018 - 14:35

NORTHVALE, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ) today reported positive topline results from a pilot study conducted for SequestOx™, Elite’s [...]

Medtronic and Philips Partner to Innovate in Lung Cancer Management

30/01/2018 - 14:31

Healthcare Leaders Join to Streamline and Optimize the Management of Lung Nodules DUBLIN and AMSTERDAM - January 30, 2018 - In a collective effort to improve the management of patients with lung nodules, Medtronic plc ( [...]

BLVD Centers Announces Expansion Into the Marijuana Market With a Plan to Monetize Certain Marijuana Strains, as Well as Offering Craving Management Products From Its New Marijuana Companion Product Line Weedaide™

30/01/2018 - 14:30

Third Quarter Financial Results; Highlights 9% Quarterly Revenue Growth; Update on Treatment Center Expansion NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES [...]

United Health Products Issues Update on HemoStyp®South Korea MFDS Application

30/01/2018 - 14:30

HENDERSON, Nev., Jan. 30, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]

Haven® Sun Protectant Approved in California

30/01/2018 - 14:30

DAVIS, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]

Assure Holdings Performs First Neuromonitoring Case in Louisiana

30/01/2018 - 14:30

PARKER, Colo., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring (IONM) services, has performed its first [...]

IN.PACT Admiral Demonstrates Consistent and Durable Outcomes in New Two-Year Japan Data and IN.PACT Global Critical Limb Ischemia Cohort Analysis

30/01/2018 - 14:29

Data Presented at LINC 2018 Highlight IN.PACT Admiral as Safe and Effective Treatment Option in PAD DUBLIN and LEIPZIG - January 30, 2018 - Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence [...]

athenahealth Recognized as Top Practice Management (11-75 Physicians) Service in 2018 KLAS Report

30/01/2018 - 14:05

WATERTOWN, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced top-performing [...]

Exonics Therapeutics Appoints Roger M. Perlmutter, M.D., Ph.D., to Board of Directors

30/01/2018 - 14:00

CAMBRIDGE, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Exonics Therapeutics, Inc., a biotechnology company focused on developing SingleCut CRISPR technology to repair mutations causing Duchenne muscular dystrophy and other [...]

Cambrex Expands Process Research and Development Capabilities Across North America

30/01/2018 - 14:00

EAST RUTHERFORD, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced an [...]

Tyme Announces Prostate Cancer Collaboration with Dr. Mack Roach III of UCSF

30/01/2018 - 14:00

NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced that Mack Roach III, M.D., FASTRO, FACR, [...]